Health information technology provider ZEPHYRx and MIR, Medical International Research entered into an exclusive partnership to jointly market the ZEPHYRx Remote Respiratory Monitoring (RRM) Solution. Under the new partnership, this will be the only remote patient monitoring (RPM) solution offered by MIR in North America.
ZEPHYRx is the largest reseller of MIR’s Spirobank Smart Spirometer and has been working with MIR, a global leader in medical devices and software, since its inception in 2019.
“Remote respiratory monitoring has evolved from being a nice-to-have to a necessity since COVID, especially for those with chronic respiratory conditions such as COPD, cystic fibrosis, pulmonary fibrosis, and asthma,” says Dwight Cheu, ZEPHYRx CEO. “But beyond the pandemic, our solution offers improved care models including far greater frequency of monitoring vs. in-clinic appointments, just-in-time respiratory testing, and gamification to support patient adherence.”
Cheu adds, “This new partnership greatly expands the visibility of our solutions for customers looking to extend their practice and clinical research beyond its physical walls and into the patient’s home. Just imagine the possibilities.”
Feature image: ZEPHYRx remote respiratory monitoring solution featuring real-time video coaching. Photo: ZEPHYRx
